A Euglycemic Insulin Clamp Study in Type 1 Diabetic Patients With Oral Insulin (ORAMED)
Phase of Trial: Phase II
Latest Information Update: 27 Mar 2019
Price : $35 *
At a glance
- Drugs Insulin (Primary)
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Oramed Pharmaceuticals
- 31 Aug 2018 Biomarkers information updated
- 15 Jun 2017 Status changed from recruiting to completed.
- 11 Jan 2017 Planned End Date changed from 1 Dec 2016 to 1 Apr 2017.